🔴 Painreform is trading 5.9% down in pre-market with broader markets also lower

Painreform is trading 5.9% down at $0.71 in pre-market on October 30, 2026, with broader market weakness possibly contributing.

• No new company-specific announcement explaining the move surfaced in the available search.
• The latest identified update was an October 23 shareholder letter covering cash, a planned Phase 2 trial, and GridFeed.
• The Nasdaq was down 2.34% and the S&P 500 down 1.02% pre-market; this does not establish a direct cause for Painreform’s decline.